Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 92%
filed 2026-06-17
Item 8.01
The Company entered into an underwriting agreement on June 15, 2026, to offer and sell 14,000,000 shares of common stock through a forward sale mechanism, with an additional 2,100,000 shares subject to an underwriter option. This is a material equity issuance that will dilute existing shareholders. Although structured as a forward sale (with settlement expected by June 16, 2027), the Company will receive net proceeds and contribute them to its operating partnership for acquisitions and general corporate purposes, making this a dilutive capital raise transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-17
Item 1.01
Magnachip entered into an At Market Issuance Sales Agreement (ATM) on June 17, 2026, authorizing the sale of up to $50 million in common stock shares through B. Riley Securities. ATM offerings are classic dilutive equity issuances that signal capital raising and potential shareholder dilution. The material nature is confirmed by the $50 million aggregate offering price and the company's stated use of proceeds for strategic growth initiatives in AI data centers and robotics.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-17
Item 1.01
The Company entered into a Securities Purchase Agreement to issue 15,000,000 shares of common stock for $3,750,000 in proceeds to three investors. This is a private placement of unregistered equity securities, which is a classic dilutive issuance event. The substantial share count and capital raise would materially affect a reasonable investor's assessment of ownership dilution and the company's financing strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-17
Item 3.02
Collective Acquisition Corp. II completed unregistered sales of equity securities, including exercise of an over-allotment option generating $33 million in additional proceeds and a related private placement of $330 thousand, as part of the SPAC's IPO capitalization.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-17
Item 1.01
The Company amended pre-funded warrants originally issued in October 2025 to remove exercisability restrictions, enabling R01 Fund LP and Framework Ventures IV L.P. to exercise their warrants on a cashless basis, resulting in the issuance of an aggregate of 22,614,600 shares of Common Stock and increasing outstanding shares from approximately 27.8 million to 50.4 million shares.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-17
SharonAI Holdings entered into Securities Purchase Agreements on June 17, 2026 for a private offering of approximately 6.7 million shares of Class A ordinary common stock at $68.73 per share, pre-funded warrants, and $600 million of 4.75% Convertible Senior Notes due 2032, generating approximately $1.5 billion in aggregate gross proceeds. The convertible notes are convertible into up to approximately 13.1 million shares of Common Stock at an initial conversion price of $95.66 per share. This is a material dilutive equity issuance raising substantial capital for the company's NVIDIA compute collaboration and AI Factory expansion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-17
Liberty Star entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC to issue a $73,700 convertible promissory note with 10% Original Issue Discount, convertible into common stock. This is a dilutive issuance of equity securities (via conversion rights embedded in the convertible note), a material financing event for a small-cap uranium exploration company that signals capital-raising pressure and future shareholder dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-17
Item 1.02
XCF Global terminated a $50 million equity purchase agreement with Helena Global Investment Opportunities I LTD. that had reserved approximately 55 million shares for potential issuance. While the termination itself eliminates dilution risk, the core event disclosed is the unwinding of a dilutive equity arrangement that previously posed material overhang and dilution concerns. The filing emphasizes the reduction in "potential dilution and associated market overhang," indicating this was a material equity issuance arrangement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-17
Item 3.02
The filing references a "Common Shares Purchase Agreement dated June 16, 2026" as Exhibit 10.1, which is the hallmark disclosure of a dilutive equity issuance. Although the Item 3.02 section itself is not provided in full, the exhibit and the boilerplate language disclaiming any offer to sell shares are consistent with a private placement or PIPE transaction. The presence of an executed purchase agreement for common shares indicates a material equity issuance that would dilute existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-17
The filing discloses a firm commitment underwritten offering of 592,270 shares of common stock and 296,135 warrants, with gross proceeds of approximately $5.95 million (inclusive of over-allotment exercise). This is a registered equity issuance under an effective S-3 shelf registration statement, representing a dilutive capital raise material to investors' assessment of ownership and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-17
Item 3.02
Dell disclosed the issuance of 3,438,364 shares of Class C common stock upon conversion of Class B common stock held by Silver Lake entities. While technically a conversion rather than a new issuance, this represents a dilutive equity event involving unregistered securities (relying on Section 3(a)(9) exemption) and a material change in the capital structure, with Class B shares declining from approximately 47.8M to 44.4M outstanding. The conversion by a significant shareholder (Silver Lake) is material to investors assessing ownership and control dynamics.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-17
Item 3.02
The filing discloses unregistered sales of Class C common stock on three dates (April 15, May 14, and June 12, 2026) totaling 573,657 shares for approximately $9.6 million in aggregate consideration. Item 3.02 specifically governs unregistered equity issuances, and the company explicitly states the sales were exempt under Section 4(a)(2) and Regulation S. This is a classic dilutive issuance that would materially affect a reasonable investor's assessment of share dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-17
Item 3.02
North Haven Net REIT sold an aggregate of 125,617 Class I shares and 15,966 Class F-I shares for approximately $2.94 million in total consideration to a feeder vehicle, with the sale exempt from registration under Section 4(a)(2) and Regulation D Rule 506. This is a classic unregistered private placement of equity securities, which Item 3.02 is designed to capture and which materially affects shareholder equity and ownership structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-16
Item 1.01
Isabella Bank Corporation entered into an Equity Distribution Agreement with Piper Sandler & Co. to issue and sell up to $30 million of common stock through an "at the market offering" under Rule 415. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution. The $30 million offering size and explicit authorization for ATM sales and private placements are hallmarks of a dilutive_issuance event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-16
Item 8.01
PTC Therapeutics announced the pricing of a $500 million convertible notes offering (with an additional $50 million option), which will result in shares of common stock issuable upon conversion. The notes are unregistered securities sold pursuant to an exemption from Securities Act registration. This is a material dilutive issuance that raises substantial capital and creates future equity dilution through conversion rights.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 35%
filed 2026-06-16
Item 8.01
Safehold Inc. disclosed a private placement of $225 million in Senior Notes under a note purchase agreement, offered in reliance on Section 4(a)(2) of the Securities Act without registration. While this is a debt issuance rather than an equity issuance, the unregistered nature and private placement structure align with the dilutive_issuance category's focus on unregistered securities sales. However, the event is fundamentally a debt financing, not an equity dilution, which creates genuine uncertainty about the best classification.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-16
EX-99.1
YY Group announced completion of a US$20 million At-The-Market (ATM) equity offering program, raising gross proceeds with net proceeds of approximately US$19.1 million after sales commissions and expenses. ATM offerings are unregistered equity issuances that dilute existing shareholders. The company explicitly states the program is now "concluded" with "no further share sales" under this facility, confirming full utilization of the offering capacity. This is a material capital-raising event affecting shareholder equity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-16
Item 3.02
The filing discloses an unregistered sale of 78,445 Class ER-A Common Shares for $2.3 million gross proceeds under a continuous private placement offering of up to $2.165 billion. The Company explicitly states reliance on Section 4(a)(2) and Regulation D Rule 506(c) exemptions from Securities Act registration requirements, which is the hallmark of a dilutive private equity issuance. This is material as it represents ongoing capital raising that dilutes existing shareholders and signals the Company's financing strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-16
The filing discloses multiple unregistered equity issuances: (1) 366,941 shares of Series G Convertible Preferred Stock issued to Ascent in exchange for promissory notes totaling ~$3.3M in principal; (2) 250,000 shares of common stock issued to Eastward Fund Management as consideration under a loan amendment. These are dilutive equity issuances exempt from registration under Section 3(a)(9) and Regulation D, typical of cash-strapped companies raising capital. While the filing also covers debt restructuring and an executive departure, the primary material event disclosed is the dilutive equity issuance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-16
The filing discloses a private placement of unregistered securities under Item 3.02, including a $290,000 convertible promissory note with a 12% interest charge and a warrant to purchase 250,000 shares at $0.50 per share. The aggregate shares issuable under both instruments are capped at 1,569,579 shares absent shareholder approval, representing significant dilution. The company received net cash proceeds of $224,500, indicating a capital raise typical of dilutive equity issuances at smaller public companies.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-16
Vivos announced its intention to file a registration statement for a proposed rights offering that would distribute transferable subscription rights to shareholders as a dividend. The rights would allow holders to purchase common stock at a specified exercise price, with potential for subsequent rights upon exercise. This is a dilutive equity issuance that would increase share count and is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-16
Item 8.01
Bandwidth Inc. announced a private offering of $275 million principal amount of 0% convertible senior notes due 2032 pursuant to Rule 144A. Convertible notes are inherently dilutive securities that will likely convert to equity, representing a material capital raise that would affect investor assessment of the company's capitalization and ownership structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-16
Item 8.01
California Resources Corporation announced a private offering of $550 million in senior notes due 2035. While this is a debt issuance rather than an equity issuance, it represents a material capital-raising activity that would affect a reasonable investor's assessment of the company's capital structure and financial obligations. The substantial principal amount and fixed coupon rate (7.250%) are material to the registrant's financial position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-16
Item 1.01
CEL-SCI Corporation completed a registered public offering of 2,500,000 shares of common stock at $1.00 per share, raising $2.5 million in gross proceeds. The offering was priced and closed on June 14-16, 2026, with proceeds designated for development and working capital.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-16
Item 8.01
EquipmentShare.com announced a private offering of $1,050 million in senior secured second lien notes due 2034 to qualified institutional investors under Rule 144A and to non-U.S. persons under Regulation S. This unregistered debt issuance materially increases the company's leverage and financial obligations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-16
Item 8.01
EquipmentShare.com announced an upsized private offering of $1,350 million in senior secured second lien notes due 2034, representing a $300 million increase from the previously announced size. The notes were offered to qualified institutional investors under Rule 144A and to non-U.S. persons under Regulation S, both exemptions from registration. While technically debt rather than equity, this unregistered capital raise is material to investors assessing the company's financial structure and dilution of existing security holders' claims.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-06-16
EX-99.1
The announcement discloses board approval of a warrant exercise price adjustment from $5.50 to $0.87 per share, a dramatic reduction that substantially increases the likelihood of warrant exercise and dilution to existing shareholders. The Company explicitly states the adjustment is intended to "incentivize participation" and generate capital through warrant exercises. This is a material capital-raising event that directly affects shareholder equity and ownership percentage.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-16
The 6-K discloses the closing of a $10 million registered direct offering of 9.3 million Class A ordinary shares at $0.20 per share plus 40.7 million pre-funded warrants at $0.1999 per warrant, exercisable at $0.0001. This is a material dilutive equity issuance that raises capital through the sale of registered securities and warrants, which would significantly affect a reasonable investor's assessment of ownership dilution and the company's capital structure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-06-15
Alvotech terminated its ATM (At-The-Market) prospectus supplement on June 15, 2026, suspending its ability to issue ordinary shares under the Open Market Sale Agreement with Jefferies LLC dated June 14, 2024. While this is technically a termination rather than an issuance, it represents a material change to the Company's capital-raising capacity and signals a strategic shift away from equity financing. The termination of an active ATM program is material to investors assessing the registrant's liquidity and financing flexibility.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-15
Item 8.01
NeoGenomics announced the commencement of a proposed offering of convertible senior notes due 2032 to qualified institutional buyers under Rule 144A. Convertible notes are inherently dilutive securities that can be converted into equity, making this a material capital-raising event that would affect investor assessment of share dilution and the company's financing strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-15
Item 3.02
As part of the Flatrock acquisition, Natural Gas Services Group issued 241,803 shares of common stock to the sellers in reliance on Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-06-15
Lotus Technology entered into a convertible note purchase agreement with Geely International for US$128.3 million in principal amount on June 12, 2026. The note is convertible into ordinary shares or ADSs at the investor's option starting 30 trading days after issuance, with conversion price based on volume-weighted average price. This is a material private placement of a convertible security that carries dilutive equity conversion rights, fitting the dilutive_issuance category. The high principal amount and equity conversion feature make this material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-15
Item 8.01
The Company commenced a private offering of green senior unsecured notes on June 15, 2026, guaranteed by multiple subsidiaries. While this is a debt issuance rather than equity, the disclosure of a material capital raise through a private offering in Item 8.01 is a significant financing event that would affect investor assessment of the registrant's capital structure and financial position. The preliminary offering memorandum included substantial company updates on assets under management ($16 billion), investment strategy, and market outlook, indicating materiality to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-15
Item 3.02
Comtech issued unregistered Lender Warrants and underlying Warrant Shares under Section 4(a)(2) exemption, likely as part of a financing arrangement related to the pending transaction with Gilat Satellite Networks.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-15
Item 8.01
The Company issued 3,280,666 shares of Class A common stock on June 15, 2026, in satisfaction of earnout obligations under the Business Combination Agreement. This represents a dilutive issuance of equity securities triggered by achievement of stock price targets. The disclosure notes that 9,841,948 shares have been issued cumulatively under the earnout structure, which is material to shareholders' ownership and voting interests.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-15
Item 1.01
PDS Biotechnology closed a Securities Purchase Agreement with YA II PN, LTD. on June 15, 2026, issuing a $6,000,000 promissory note convertible into common stock and a warrant to purchase 2,158,274 shares at $1.1824/share, plus establishing a $50,000,000 at-the-market offering program. This private placement under Section 4(a)(2) and Regulation D Rule 506 materially dilutes shareholder equity and voting power.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-06-15
Item 3.02
Kimco Realty issued $600 million in 3.50% Exchangeable Senior Notes due 2031 (with an additional $75 million option exercised, totaling $675 million) under Section 4(a)(2) and Rule 144A, with up to 23.6 million shares of common stock potentially issuable upon exchange. The exchangeable feature, substantial dilutive potential, and capital-raising nature of this unregistered transaction are material to investors' assessment of ownership dilution and the company's financing activities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-06-15
Item 1.01
Momentus consummated a registered direct offering of 1,851,852 shares of Class A common stock at $13.50 per share on June 15, 2026, raising approximately $25.0 million in gross proceeds. The offering included lock-up restrictions and warrant issuance to the placement agent, materially diluting existing shareholders and affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-15
Item 3.02
Item 3.02 discloses an unregistered sale of equity securities—specifically, the issuance of "Consideration Shares to the Seller pursuant to the Purchase Agreement" under Section 4(a)(2) exemption. This is a classic dilutive issuance structure, likely part of an M&A transaction where equity is used as consideration. The unregistered nature and reference to a Purchase Agreement indicate a material capital event affecting shareholder equity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-15
Item 8.01
Strategy Inc sold 1,732,553 shares of Class A Common Stock under its at-the-market offering program during June 8-14, 2026, generating $209.0 million in net proceeds. The company has a $21.0 billion MSTR Increase announced on March 23, 2026, with $25.7 billion remaining capacity available for issuance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-15
Item 1.01
Super Micro Computer entered into an underwriting agreement on June 10, 2026 to issue and sell 75 million depositary shares representing interests in 7.00% Series A Mandatory Convertible Preferred Stock, with an additional 11.25 million shares available via an over-allotment option. The registered public offering closed on June 15, 2026, raising capital through a shelf registration statement while diluting existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-15
Item 1.01
Arcadia Biosciences entered into a securities purchase agreement on June 11, 2026, for a private placement of pre-funded warrants and investment options to purchase approximately 11.6 million shares of common stock with gross proceeds of ~$4 million. The unregistered securities were sold to accredited institutional investors under Section 4(a)(2) and Rule 506(b), with exercise prices of $0.0001 and $0.91 per share, immediate exercisability, and cashless exercise rights, representing a material dilutive equity issuance typical of PIPE-like financings.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-15
Item 8.01
The Company announced an intended offering of $250 million in convertible senior notes due 2031 to qualified institutional buyers, with an additional $37.5 million option. Convertible notes are dilutive securities that create potential equity dilution upon conversion. While the filing also mentions a business separation, the primary 8-K disclosure centers on the convertible debt offering, which is a material capital-raising event typical of dilutive issuances.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-06-15
The Company exchanged 1,330 Series A convertible preferred shares held by an investor for 1,330 newly created Series B convertible preferred shares with substantially identical terms. While technically an exchange rather than a new issuance, the creation of new Series B Preferred Shares with conversion rights represents a dilutive capital structure modification. The transaction involves convertible securities that could dilute common equity upon conversion, and the Certificate of Designations was adopted to establish the new preferred class, making this a material capital event affecting shareholder interests.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-15
The filing discloses unregistered sales of 6,070,948 shares of common stock by certain stockholders, with 3,019,066 shares acquired in connection with the acquisition of Omnisys Ltd. and 3,051,882 shares acquired in connection with the acquisition of Indo Earth Moving Ltd. Item 3.02 explicitly references unregistered sales of equity securities exempt under Regulation S, and the prospectus supplement covers resale of these shares. This represents a dilutive issuance material to investors assessing ownership and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-06-15
Item 1.01
Zeo Energy Corp. entered into a Note Purchase Agreement with White Lion Capital on June 9, 2026, to issue convertible notes with aggregate funded potential of $7.5 million. The convertible notes are convertible into Class A Common Stock at a conversion price subject to ownership limitations and a 19.99% Conversion Cap, with the Company obligated to seek stockholder approval for issuances exceeding the cap.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-15
Item 3.02
Matternet completed a subsequent closing of a private placement, issuing 339,666 shares of common stock at $3.00 per share for approximately $1.0 million in gross proceeds to accredited and institutional investors under Section 4(a)(2) and Rule 506(b) of Regulation D.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-06-15
Item 1.01
Healthcare Triangle completed a private placement of $4.235 million principal amount of convertible notes (gross proceeds ~$3.6 million) and entered into a $50 million equity line of credit with Hudson Global Ventures. Both transactions involve unregistered equity issuances with significant dilution potential: the convertible notes are convertible at 85% of VWAP (floor $0.452/share), and the equity line permits up to $50 million in future share purchases at 94% of market prices, with an additional warrant for 50,000 shares at nominal exercise price.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-15
Item 3.02
RenX issued unregistered equity securities including Preferred Stock, Warrants, and Common Stock upon conversion and exercise, relying on Section 3(a)(9) and Section 4(a)(2)/Regulation D exemptions from Securities Act registration, creating substantial ownership dilution.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-15
EX-99.1
This press release announces a registered direct offering of 53,333,333 Class A Ordinary Shares (or pre-funded warrants) at $0.15 per share, raising approximately $8 million gross proceeds. The offering is being made pursuant to a shelf registration statement on Form F-3, making it a registered equity issuance. This represents a significant dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership and capital structure.
View raw filing on EDGAR →